相关实验视频
Updated: Jun 27, 2025

11:19
Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
1.5K
一个青少年女性的耐火性慢性便秘,后来被诊断为内神经的内失调症
Farah Slaczka1, Roshan Uruthirakumar1, Mateusz Slaczka1
1Pediatric Surgery, Trinity School of Medicine, Warner Robins, USA.
Cureus
|April 29, 2024
概括
内部关节 (IASA) 是儿童慢性便秘的一个罕见原因. 结直肠活检对于将IASA与希尔施普隆病区分开来至关重要,使得及时治疗能够改善生活质量.
科学领域:
- 胃肠病学 胃肠病学
- 儿科手术 儿科手术
- 阳门疾病 阳门疾病
背景情况:
- 内部关节 (IASA) 是一种罕见的直肠疾病,在儿科患者中引起慢性耐火性便秘.
- 由于对常规疗法的反应不佳,它经常被误诊为超短段春病.
研究的目的:
- 这份病例报告强调了一个罕见的IASA案例,发生在一个青少年女性身上.
- 它强调了直肠活检的诊断重要性,以区分IASA和赫施普隆病.
- 目标是促进早期的有针对性的治疗,并提高患者的生活质量.
主要方法:
- 诊断包括直肠测量和直肠吸液活检.
- 该案例说明了通过活检发现来区分IASA和赫施普隆病的诊断过程.
- 管理包括每两年一次的近内毒素注射.
主要成果:
- 结直肠活检证实了质细胞的存在,排除了赫施普朗格病.
- 肉毒毒素注射可暂时缓解大约六个月的症状.
- 潜在的病理生理学涉及到改变的内置和缺陷的神经肌肉结合在内部关节.
结论:
- 准确的IASA诊断,通过活检将其与赫施普隆病区分开来,对于有效的管理至关重要.
- 毒素注射提供了暂时的缓解,而手术肌切除术可能会提供长期改善.
- 早期和正确的诊断可以改善儿科患者慢性耐火性便秘的管理策略.
关键词:
关节杆肌切除术 (myectomy) 是一种关节肌切除术.博托克斯注射 博托克斯注射慢性便秘 慢性便秘内部门关节 achalasia 的情况.儿科胃肠病学 儿科胃肠病学儿科外科手术 儿科外科手术更多相关视频
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Assessment of the Rectum and Anus
205
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
205
Drugs for Treatment of Diarrhea-Predominant IBS
161
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
157
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
157
Irritable Bowel Syndrome III: Medical and Nursing Management
197
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
197

